068940 — Cellfie Global Co Balance Sheet
0.000.00%
TechnologyHighly SpeculativeMicro Cap
Annual balance sheet for Cellfie Global Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Interim Report | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 16,421 | 13,918 | 19,216 | 9,793 | 4,808 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,195 | 2,621 | 2,536 | 6,608 | 5,005 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 27,513 | 26,448 | 31,355 | 29,437 | 22,537 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 6,708 | 6,671 | 7,052 | 8,755 | 7,958 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 35,866 | 35,258 | 39,925 | 43,562 | 34,079 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16,260 | 13,228 | 22,131 | 15,535 | 12,115 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 21,049 | 18,353 | 32,037 | 17,904 | 13,784 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 14,817 | 16,906 | 7,888 | 25,658 | 20,295 |
Total Liabilities & Shareholders' Equity | 35,866 | 35,258 | 39,925 | 43,562 | 34,079 |
Total Common Shares Outstanding |